Related Experiment Video

Updated: Aug 29, 2026

Comparison of Two Representative Methods for Differentiation of Human Induced Pluripotent Stem Cells into Mesenchymal Stromal Cells
06:24

Comparison of Two Representative Methods for Differentiation of Human Induced Pluripotent Stem Cells into Mesenchymal Stromal Cells

Published on: October 20, 2023

Prader-Willi syndrome: advances in genetics, pathophysiology and treatment

Anthony P Goldstone1

  • 1Department of Endocrinology, St Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK. tgoldstone@yahoo.com

Trends in Endocrinology and Metabolism: TEM
|December 25, 2003
PubMed

Insights

Prader-Willi syndrome (PWS) is a genetic disorder caused by missing paternal genes on chromosome 15. Research explores PWS genetics, phenotypes, and potential treatments for this complex obesity syndrome.

Area of Science:

  • Genetics
  • Endocrinology
  • Neuroscience

Background:

  • Prader-Willi syndrome (PWS) is a complex genetic disorder resulting from the absence of paternally inherited imprinted genes on chromosome 15q11-q13.
  • Recent discoveries of the imprinting control center and novel imprinted genes have intensified interest in PWS as a human obesity syndrome.
  • Understanding PWS is crucial for a range of endocrine, pediatric, and neuropsychiatric conditions.

Purpose of the Study:

  • This review synthesizes current knowledge on Prader-Willi syndrome.
  • It focuses on the genetic basis, phenotypic manifestations, and hypothalamic studies in PWS.
  • The review also discusses current and future management strategies for PWS and its associated complications.

Main Methods:

  • Review of literature on the chromosomal region and candidate genes linked to PWS.
  • Analysis of metabolic and hormonal phenotypes observed in PWS patients.
  • Examination of postmortem studies of human PWS hypothalami.
  • Synthesis of information on current and potential therapeutic advances.

Main Results:

  • The review details the chromosomal region and candidate genes implicated in PWS.
  • It links specific PWS phenotypes to findings from mouse models.
  • Metabolic and hormonal abnormalities characteristic of PWS are discussed.
  • Insights from human hypothalamic studies in PWS are presented.

Conclusions:

  • Advances in understanding PWS genetics and phenotypes are highlighted.
  • Potential therapeutic strategies for managing PWS and its complications are explored.
  • This research offers insights applicable to broader endocrine, pediatric, and neuropsychiatric diseases.

More Related Videos

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

Related Concept Videos

Pleiotropy01:47

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...